The accumulated knowledge in cancer immunology and encouraging results from recent cancer immunotherapy clinical trials indicate that immune system plays an essential role in host defense against cancer and can be exploited for effective cancer therapy. However, the existing gap between laboratory and clinical investigators severely hampers the translation of fundamental discoveries into clinical applications. The main goal of this meeting is to provide a joint forum for leading basic researchers and clinical investigators in the fields of cancer immunology and immunotherapy that would serve to accelerate translation of basic research into effective treatment of cancer in children and adults.
Thus, the field of Cancer Immunotherapy and Immunomonitoring (CITIM) is of escalating significance. CITIM Conference allows scientists, clinicians, medical practitioners and specialists, students, R&D experts and patients to meet together and discuss the latest therapeutic, preventive and diagnostic developments in the field.
For more info: https://www.canceritim.org/program
President Björn Rúnar Lúðvíksson (Iceland)
bjornlud(at)landspitali.is / Tel: +354 543 5800
Treasurer Hanna Jarva (Finland)
Hanna.Jarva(at)helsinki.fi / Tel: 02941
Secretary Marit Inngjerdingen (Norway)
mariti(at)medisin.uio.no / Tel: +47 23073769
